Methods— Data were extracted and filtered from electronic databases PubMed (MEDLINE), CINAHL, Embase, PsycINFO, and Scopus. Intervention effects were represented by Hedges’ g and combined into pooled effect sizes using random effects models. Heterogeneity was evaluated using the Chi-squared (Q) and I-squared statistics.
Results— Five studies met inclusion criteria, representing data from 182 participants. The primary analysis produced a positive overall effect of aerobic exercise on cognitive performance (Hedges’ g [95% confidence interval]= 0.42 [0.007–0.77]). Effects were significantly different from zero for aerobic interventions combined with other physical activity interventions (Hedges’ g [CI] =0.59 [0.26 to 0.92]), but not for aerobic interventions alone (P= 0.40). In specific subdomains, positive moderate effects were found for global cognitive function (Hedges’ g [CI] =0.79 [0.31 to 1.26]) but not for attention and processing speed (P=0.08), executive function (P= 0.84), and working memory (P=0.92).
Conclusions— We determined that aerobic exercise combined with other modes of training produced a significant positive effect on cognition in adults after stroke in the subacute and chronic phases. Our analysis supports the use of combined training as a treatment option to enhance long-term cognitive function in adults after stroke. Further research is needed to determine the efficacy of aerobic training alone.
The article highlights the damage COVID-19 can cause by attacking brain tissue which can lead to several neurological disorders; it is a collection of systematic review and meta-analysis reviews as well as different scientific studies. The article addresses the background of COVID-19 and the distinction between Long COVID and COVID-19, along with the general pathway that the virus of COVID-19 takes to infect a cell at a cellular level. The variety of symptoms that individuals experience can be a topic of interest, and this article discusses the variability in COVID-19 infection. Moreover, SARS-COV-2 can enter the body in different ways and attack different types of cells within the body, thus the article brings attention to the different mechanisms of infection. Due to the brain damage that can be caused by COVID-19, there are several neurological disorders the article addresses including status epilepticus, stroke, acute necrotizing encephalopathy, encephalitis, hypogeusia, hyposmia, guillain-barre syndrome, and systemic inflammatory response syndrome. Although these disorders have different routes of treatment, the article briefly talks about general treatments for COVID-19 that include antiviral drugs, immune modulators, and monoclonal antibody treatment. Given the significance of COVID-19, more research should be done to understand the variety of neurological disorders that can be an effect of COVID-19 infection.
Does training in the upper extremity domain with startle translate to the speech domain post-stroke?
The aim of this study was to assess whether exposing individuals who are 6-month post-stroke with an upper extremity motor deficit and some form of speech impairment (aphasia and/or apraxia) to upper extremity training utilizing Startle Adjuvant Rehabilitation Therapy (START) would result in improvement in symptoms of speech impairment. It was hypothesized that while scores on Diadochokinetic Rate (a measure of apraxia) and Repetition (a measure of aphasia) would improve by timepoint with START as compared to the Control group, measures of aphasia including Spontaneous Speech, Auditory Verbal Comprehension, and Naming would not be different in scores by timepoint. Subjects were recruited from two separate ongoing studies consisting of three days of similar upper extremity training on certain functional tasks with and without START and the speech assessments utilized were pulled from the Western Aphasia Battery (Revised) and Apraxia Battery for Adults 2nd Edition. It was found that there were no statistically significant differences by timepoint in either condition for any of the speech assessments. This proof-of-concept study is the first to assess whether the StartReact effect, when applied to the upper extremity domain, will translate into measurable improvements in speech impairment despite the lack of any speech training.